XML 59 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Supplementary Insurance Information
 12 Months Ended
Dec. 31, 2023
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]  
Consolidated Supplementary Insurance Information
MetLife, Inc.
Schedule III
Consolidated Supplementary Insurance Information
December 31, 2023 and 2022
(In millions)
SegmentDAC
and
VOBA
Future Policy Benefits,
Other Policy-Related
Balances and
Policyholder Dividend
Obligation
Policyholder
Account
Balances		Market Risk Benefits (Assets) Liabilities (1)Policyholder
Dividends
Payable		Unearned 
Premiums (2), (3)		Unearned
Revenue (2)
2023
Group Benefits (4)
$258 $17,863 $7,692 $— $— $446 $— 
RIS (4)
413 71,223 82,405 (13)— 7 31 
Asia
11,983 35,683 92,063 234 75 1,532 2,850 
Latin America
2,447 14,636 6,368 — — 2 989 
EMEA
1,731 3,463 7,578 (53)— 18 608 
MetLife Holdings
3,289 72,410 23,178 2,722 311 155 59 
Corporate & Other
30 864 (15)3 — — — 
Total
$20,151 $216,142 $219,269 $2,893 $386 $2,160 $4,537 
2022
Group Benefits (4)
$264 $16,971 $8,028 $— $— $349 $— 
RIS (4)
286 64,376 80,066 8 — 3 36 
Asia
11,560 34,642 84,165 284 72 1,889 2,382 
Latin America
2,087 13,426 5,383 — — 2 848 
EMEA
1,607 3,269 7,289 (37)— 14 559 
MetLife Holdings
3,819 71,914 25,688 3,225 315 158 281 
Corporate & Other
30 1,048 (22)3 — — — 
Total
$19,653 $205,646 $210,597 $3,483 $387 $2,415 $4,106 
__________________
(1)MRBs assets and liabilities are presented net.
(2)Amounts are included within the future policy benefits, other policy-related balances and policyholder dividend obligation column.
(3)Includes premiums received in advance.
(4)See Note 2 for information on the reorganization of the Company’s segments.
MetLife, Inc.
Schedule III
Consolidated Supplementary Insurance Information — (continued)
Years Ended December 31, 2023, 2022 and 2021
(In millions)
SegmentPremiums and
Universal Life
and Investment-Type
Product Policy Fees		Net
Investment
Income		Policyholder Benefits and
Claims, Policyholder Liability Remeasurement (Gains) Losses and Interest Credited to Policyholder Account Balances
Market Risk Benefit Remeasurement (Gains) Losses
Amortization of
DAC and
VOBA
Charged to
Other
Expenses		Other
Expenses (1)
2023
Group Benefits (2)
$22,436 $1,148 $19,329 $— $26 $3,778 
RIS (2)
8,561 7,354 14,057 (29)49 403 
Asia
6,883 4,307 6,941 (43)794 1,562 
Latin America
5,685 1,610 4,801 — 468 1,263 
EMEA
2,314 885 1,737 (40)348 807 
MetLife Holdings
3,513 4,234 5,517 (882)258 1,527 
Corporate & Other
43 370 23 — 9 2,040 
Total
$49,435 $19,908 $52,405 $(994)$1,952 $11,380 
2022
Group Benefits (2)
$21,906 $1,081 $19,226 $— $26 $3,460 
RIS (2)
13,923 5,899 18,124 (314)40 380 
Asia
7,256 3,571 6,199 (90)745 1,601 
Latin America
4,399 1,318 4,092 — 410 1,032 
EMEA
2,298 (864)30 (126)331 778 
MetLife Holdings
3,968 4,633 5,849 (3,144)270 1,632 
Corporate & Other
(15)278 (5)— 9 1,851 
Total
$53,735 $15,916 $53,515 $(3,674)$1,831 $10,734 
2021
Group Benefits (2)
$21,304 $1,102 $19,929 $— $26 $3,158 
RIS (2)
5,334 6,606 8,928 96 37 368 
Asia
8,047 5,110 7,386 (48)786 1,758 
Latin America
3,749 1,207 3,475 — 372 978 
EMEA
2,803 932 2,085 (120)389 900 
MetLife Holdings
4,256 6,093 6,097 (1,161)320 1,845 
Corporate & Other (3)
903 345 617 (4)107 1,854 
Total
$46,396 $21,395 $48,517 $(1,237)$2,037 $10,861 
______________
(1)Includes other expenses and policyholder dividends, excluding amortization of DAC and VOBA charged to other expenses.
(2)See Note 2 for information on the reorganization of the Company’s segments.
(3)Includes activity related to MetLife P&C, a former subsidiary of the Company, that was previously reported in the former U.S. segment. See Notes 2 and 3.